Current status of 10B-neutron capture therapy: enhancement of tumor dose via beam filtration and dose rate, and the effects of these parameters on minimum boron content: a theoretical evaluation.

No abstract is available for this paper.

• Publication year

  1985

• Venue

  International Journal of Radiation Oncology, Biology, Physics

• Publication date

  1985-04-01

• Fields of study

  Medicine, Physics

• Identifiers
  DOI 10.1016/0360-3016(85)90318-9PMID 3980279
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The relative biological effectiveness in V79 Chinese hamster cells of the neutron capture reactions in boron and nitrogen.

  1984cited by this paper
• Coupling of dextrans conjugated with boron to gamma globulin: a model for NCT

  1983cited by this paper
• Chlorpromazine distribution in hamsters and mice bearing transplantable melanoma.

  1982cited by this paper
• Radiation enhancement with iodinated deoxyuridine.

  1982cited by this paper
• Thiouracil distribution in mice carrying transplantable melanoma.

  1982cited by this paper
• Dosimetric implications of new compounds for neutron capture therapy (NCT)

  1982cited by this paper
• Filtered reactor beams for fast neutron capture γ-ray experiments

  1976cited by this paper
• Boron neutron capture therapy for the treatment of cerebral gliomas. I. Theoretical evaluation of the efficacy of various neutron beams.

  1975cited by this paper
• Development and dosimetry of an "epithermal" neutron beam for possible use in neutron capture therapy. II. Absorbed dose measurements in a phantom man.

  1966cited by this paper
• Development and Dosimetry of an `Epithermal' Neutron Beam for Possible Use in Neutron Capture Therapy I. `Epithermal' Neutron Beam Development

  1965cited by this paper

• Neutron relative biological effectiveness factors in boron neutron capture therapy: Estimation of their values from the secondary charged particles and evaluation of weighted kerma factors for a standard tissue.

  2025cites this paper
• Boron-Containing MOF Nanoparticles with Stable Metabolism in U87-MG Cells Combining Microdosimetry To Evaluate Relative Biological Effectiveness of Boron Neutron Capture Therapy.

  2024cites this paper
• Using ANN for thermal neutron shield designing for BNCT treatment room

  2024cites this paper
• Development of a New Image Reconstruction Method Using Bayesian Estimation with Limited View-Angle Projection Data for BNCT-SPECT

  2024cites this paper
• Quantification of boron in cells for evaluation of drug agents used in boron neutron capture therapy

  2021cites this paper
• Functional nanocomposites: promising candidates for cancer diagnosis and treatment

  2021cites this paper
• Effects of linkers on the Development of Liposomal Formulation of Cholesterol Conjugated Cobalt bis(dicarbollides).

  2020cites this paper
• Evaluation of the total distribution volume of 18F-FBPA in normal tissues of healthy volunteers by non-compartmental kinetic modeling

  2019cites this paper
• Intracellular target delivery of cell-penetrating peptide-conjugated dodecaborate for boron neutron capture therapy (BNCT).

  2019cites this paper
• Gold Nanoparticles as Boron Carriers for Boron Neutron Capture Therapy: Synthesis, Radiolabelling and In Vivo Evaluation

  2019cites this paper
• Microdistribution and quantification of the boron neutron capture therapy drug BPA in primary cell cultures of human glioblastoma tumour by NanoSIMS.

  2019cites this paper
• Nanostructured Boron Compounds for Boron Neutron Capture Therapy (BNCT) in Cancer Treatment

  2018cites this paper
• Gadolinium borate and iron oxide bioconjugates: Nanocomposites of next generation with multifunctional applications.

  2018cites this paper
• Towards carborane-functionalised structures for the treatment of brain cancer.

  2018cites this paper
• Advanced carboraneous materials

  2017cites this paper
• BİYOMEDİKAL UYGULAMALAR İÇİN ÇOK-İŞLEVLİ DEMİR OKSİT-GADOLİNYUM BORAT KOMPOZİT NANOPLATFORMLARIN GELİŞTİRİLMESİ

  2017cites this paper
• Nanostructured boron compounds for cancer therapy

  2017cites this paper
• Carborane Analog of Dopamine D3 Receptor Antagonist Eticlopride

  2016cites this paper
• Hemorrhage in mouse tumors induced by dodecaborate cluster lipids intended for boron neutron capture therapy

  2014cites this paper
• Nanomaterials for boron and gadolinium neutron capture therapy for cancer treatment

  2014cites this paper
• Quantitative evaluation of boron neutron capture therapy (BNCT) drugs for boron delivery and retention at subcellular‐scale resolution in human glioblastoma cells with imaging secondary ion mass spectrometry (SIMS)

  2014cites this paper
• Synthesis of composite Si-B nanoparticles by the laser-induced pyrolysis method

  2014cites this paper
• Dose-rate effect was observed in T98G glioma cells following BNCT.

  2014cites this paper
• Boron neutron capture therapy and 18F-labelled borophenylalanine positron emission tomography: a critical and clinical overview of the literature.

  2013cites this paper
• Evaluation of the binding of polyhedral borane anions to representative proteins.

  2013cites this paper
• Biodistribution and Subcellular Localization of an Unnatural Boron-Containing Amino Acid (Cis-ABCPC) by Imaging Secondary Ion Mass Spectrometry for Neutron Capture Therapy of Melanomas and Gliomas

  2013cites this paper
• Applications and perspectives of boron-enriched nanocomposites in cancer therapy.

  2013cites this paper
• Boron Neutron Capture Therapy

  2012cites this paper
• Boron and Gadolinium in the Neutron Capture Therapy of Cancer

  2011cites this paper
• Design and Development of Polyhedral Borane Anions for Liposomal Delivery

  2011cites this paper
• Boron Tumor Delivery for BNCT: Recent Developments and Perspectives

  2011cites this paper
• A novel method of boron delivery using sodium iodide symporter for boron neutron capture therapy.

  2010cites this paper
• Boron-containing protoporphyrin IX derivatives and their modification for boron neutron capture therapy: synthesis, characterization, and comparative in vitro toxicity evaluation.

  2010cites this paper
• Boron drug delivery via encapsulated magnetic nanocomposites: a new approach for BNCT in cancer treatment

  2010cites this paper
• Biological evaluation of boronated unnatural amino acids as new boron carriers.

  2009cites this paper
• L-amino acid transporter-1 and boronophenylalanine-based boron neutron capture therapy of human brain tumors.

  2009cites this paper
• Synthesis and characterization of azanonaborane-containing purine derivatives for boron neutron capture therapy

  2008cites this paper
• Synthesis of a series of boronated unnatural cyclic amino acids as potential boron neutron capture therapy agents

  2008cites this paper
• Investigation of the Interactions of Polyhedral Borane Anions with Serum Albumins

  2008cites this paper
• Applied Radiation and Isotopes

  2008cites this paper
• Tumor-specific targeting of sodium borocaptate (BSH) to malignant glioma by transferrin-PEG liposomes: a modality for boron neutron capture therapy

  2008cites this paper
• Synthesis and in vitro properties of trimethylamine- and phosphonate-substituted carboranylporphyrins for application in BNCT.

  2008cites this paper
• Insertion of a magnesium(II)-octacarboranyl(hexylsulfanyl) porphyrazine into liposomes: a physico-chemical study.

  2007cites this paper
• Recent Developments in Boron Neutron Capture Therapy (BNCT) Driven by Nanotechnology

  2007cites this paper
• Tumour-localizing and -photosensitising properties of meso-tetra(4-nido-carboranylphenyl)porphyrin (H2TCP).

  2007cites this paper
• Dosimetry for Neutron Capture Therapy in JRR-4

  2007cites this paper
• Synthesis, liposomal preparation, and in vitro toxicity of two novel dodecaborate cluster lipids for boron neutron capture therapy.

  2007cites this paper
• Boron-Containing Bioactive Molecules: An Approach to Boron Neutron Capture Therapy

  2006cites this paper
• Peptide-mediated cell transport of water soluble porphyrin conjugates.

  2006cites this paper
• Closomers of high boron content: synthesis, characterization, and potential application as unimolecular nanoparticle delivery vehicles for boron neutron capture therapy.

  2006cites this paper
• Total syntheses of three copper (II) tetracarboranylphenylporphyrins containing 40 or 80 boron atoms and their biological properties in EMT-6 tumor-bearing mice.

  2006cites this paper
• Homogeneous boron targeting of heterogeneous tumors for boron neutron capture therapy (BNCT): chemical analyses in the hamster cheek pouch oral cancer model.

  2006cites this paper
• Improvement of the tumor-suppressive effect of boron neutron capture therapy for amelanotic melanoma by intratumoral injection of the tyrosinase gene.

  2006cites this paper
• Boron Neutron Capture Therapy of Cancer 1

  2006cites this paper
• Boron Neutron Capture Therapy of a Murine Melanoma1

  2006cites this paper
• Unilamellar liposomes with enhanced boron content.

  2006cites this paper
• Enhanced cellular uptake with a cobaltacarborane-porphyrin-HIV-1 Tat 48-60 conjugate.

  2006cites this paper
• A novel ^10B-enriched carboranyl-containing phthalocyanine as a radio- and photo-sensitising agent for boron neutron capture therapy and photodynamic therapy of tumours: in vitro and in vivo studies

  2006cites this paper
• A simple model for quantification of the radiobiological effectiveness of the 10B(n,alpha)7Li capture reaction in BNCT.

  2006cites this paper
• Chapter 7 - Boronated saccharides: potential applications

  2005cites this paper
• Targeting normal and neoplastic tissues in the rat jejunum and colon with boronated, cationic acrylamide copolymers.

  2005cites this paper
• Pharmacokinetics of Na2B12H11SH (BSH) in patients with malignant brain tumours as prerequisite for a phase I clinical trial of boron neutron capture

  2005cites this paper
• A targeting model of boron neutron-capture therapy to hepatoma cellsin vivo with a boronated anti-(α-fetoprotein) monoclonal antibody

  2005cites this paper
• Structural characterization of cationic liposomes loaded with sugar-based carboranes.

  2005cites this paper
• Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption.

  2005cites this paper
• Synthesis and cellular studies of an octa-anionic 5,10,15,20-tetra[3,5-(nido-carboranylmethyl)phenyl]porphyrin (H(2)OCP) for application in BNCT.

  2005cites this paper
• Ligand Liposomes and Boron Neutron Capture Therapy

  2004cites this paper
• Analysis of boron‐10 in soft tissue by dynamic secondary ion mass spectrometry

  2004cites this paper
• Biodistribution of GB-10 (Na(2)(10)B10H10 compound for boron neutron capture therapy (BNCT) in an experimental model of oral cancer in the hamster cheek pouch.

  2004cites this paper
• Studies of 4-dihydroxyborylphenylalanine and its radiolabelled analogues to implement clinical trials of boron neutron capture therapy in Finland

  2004cites this paper
• for boron neutron capture therapy (BNCT) in an experimental model of oral cancer in the hamster cheek pouch

  2004cites this paper
• Boron Neutron Capture Enhancement (BNCE) of Fast Neutron Irradiation for Glioblastoma: Increase of Thermal Neutron Flux with Heavy Material Collimation, A Theoretical Evaluation

  2004cites this paper
• Biodistribution of p-borophenylalanine (BPA) in dogs with spontaneous undifferentiated thyroid carcinoma (UTC).

  2004cites this paper
• A critical assessment of boron target compounds for boron neutron capture therapy

  2003cites this paper
• Monte Carlo model of the Studsvik BNCT clinical beam: description and validation.

  2003cites this paper
• Synthesis and biological evaluation of folate receptor-targeted boronated PAMAM dendrimers as potential agents for neutron capture therapy.

  2003cites this paper
• Synthesis of homoleptic Re(I) complexes of isocyano-carboranes and the X-ray structure of hexakis(p-carboran-1-yl-isonitrile)Re(I)

  2003cites this paper
• Synthesis, toxicity and biodistribution of two 5,15-di[3,5-(nido-carboranylmethyl)phenyl]porphyrins in EMT-6 tumor bearing mice.

  2003cites this paper
• Boron Neutron Capture Therapy: Cellular Targeting of High Linear Energy Transfer Radiation

  2003cites this paper
• The first carboranyl bis(adenosine diphosphate) (CBADP): a synthetic investigation

  2003cites this paper
• Ligand liposomes and boron neutron capture therapy

  2003cites this paper
• Introductory experiments on ligand liposomes as delivery agents for boron neutron capture therapy.

  2003cites this paper
• Syntheses and preliminary biological studies of four meso-Tetra[(nido-carboranylmethyl)phenyl]porphyrins.

  2002cites this paper
• The medicinal chemistry of carboranes

  2002cites this paper
• Synthesis of 1-Amino-3-{2-[7-(6-deoxy-α/β-D-galactopyranos-6-yl)-1,7-dicarba-closo-dodecaboran(12)-1-yl]ethyl}cyclobutanecarboxylic Acid Hydrochloride

  2002cites this paper
• Selective Uptake of p-Borophenylalanine by Undifferentiated Thyroid Carcinoma for Boron Neutron Capture Therapy

  2002cites this paper
• Kinetic Mathematical Models for the ¹¹¹In-labelled Bleomycin Complex and ¹ºB in Boron Neutron Capture Therapy

  2002cites this paper
• Linkage of boronated polylysine to glycoside moieties of polyclonal antibody; boronated antibodies as potential delivery agents for neutron capture therapy.

  2002cites this paper
• Kinetic Mathematical Models for the 111 In-labelled Bleomycin Complex and 10 B in Boron Neutron Capture Therapy

  2002cites this paper
• Dynamic secondary ion mass spectrometry analysis of boron from boron neutron capture therapy drugs in co-cultures: single-cell imaging of two different cell types within the same ion microscopy field of imaging.

  2001cites this paper
• Biodistribution of Copper Carboranyltetraphenylporphyrins in Rodents Bearing an Isogeneic or Human Neoplasm

  2001cites this paper
• Boron Neutron Capture Therapy of a Murine Mammary Carcinoma using a Lipophilic Carboranyltetraphenylporphyrin1

  2001cites this paper
• Boron neutron capture therapy of a murine mammary carcinoma using a lipophilic carboranyltetraphenylporphyrin.

  2001cites this paper
• Integral and pulse mode silicon dosimetry for dose verification on radiation oncology modalities

  2001cites this paper
• Quantitative imaging and microlocalization of boron-10 in brain tumors and infiltrating tumor cells by SIMS ion microscopy: relevance to neutron capture therapy.

  2001cites this paper
• BNCT Beyond Glioma Treatment

  2001cites this paper
• Synthesis of novel boron containing unnatural cyclic amino acids as potential therapeutic agents

  2001cites this paper
• Synthesis of a water soluble boron neutron capture therapy agent: 1-amino-3-[2-(7-{3-[2-(2-hydroxymethyl-ethoxy)-1-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)ethoxy]propyl}-1,7-di-carba-closo-dodecaboran-1-yl)ethyl]cyclobutanecarboxylic acid

  2000cites this paper
• Changed delivery of boron to tumours using electroporation for boron neutron capture therapy with BSH.

  2000cites this paper
• Selective uptake of para-boronophenylalanine increases in amelanotic melanoma cells transfected by the tyrosinase gene.

  2000cites this paper